1.Safety, Efficacy, and Drug Survival of Colchicine in Recurrent Aphthous Stomatitis in a Real-World Setting
Jongwook OH ; Jae-Won LEE ; Kyung Bae CHUNG ; Dongsik BANG ; Do-Young KIM
Annals of Dermatology 2022;34(1):22-27
Background:
Recurrent aphthous stomatitis (RAS) is a common disorder characterized by episodic ulcerations in the oral mucosa. Although colchicine has been a common systemic treatment for RAS, there is still considerable uncertainty regarding its efficacy and drug survival in this setting.
Objective:
We aimed to study drug survival, efficacy, and safety of colchicine for the treatment of RAS, especially in the real clinical setting.
Methods:
Between 2012 and 2016, 150 patients given colchicine for RAS were selected for a single-centre retrospective study of real-world efficacy and drug survival.
Results:
Among the 114 patients who qualified, 81.6% showed moderate or substantial responses (>25% improvement). Gastrointestinal complications (16.7%), neutropenia (3.5%), and liver enzyme elevation (4.4%) were reported within 2 weeks after initiating treatment.Delayed adverse manifestations were rare. One year after onset, colchicine use was sustained in roughly one-half (49.5%) of patients, whereas many (30.3%) had discontinued the drug, primarily due to lack of efficacy or adverse events. In Cox proportional hazard analysis, minor ulcers were identified as potential determinants of longer drug survival owing to less probability of non-efficacy. However, major ulcers had emerged as predictors of early discontinuation due to lack of efficacy.
Conclusion
In patients with RAS, colchicine may be an effective and safe treatment amenable to long-term maintenance. Monitoring of adverse events within 2 weeks after initiating treatment is advisable to ensure safe administration.
2.Clinical and Radiographic Characteristics of Neuro-Behçet's Disease in South Korea
Seung Woo KIM ; Tae Gyun KIM ; Jongwook OH ; Do Young KIM ; Young Chul CHOI ; Seung Min KIM ; Ha Young SHIN ; Dongsik BANG
Journal of Clinical Neurology 2019;15(4):429-437
BACKGROUND AND PURPOSE: Neurological involvement in Behçet's disease [neuro-Behçet's disease (NBD)] is uncommon, but it is worth investigating since it can cause substantial disability. However, difficulties exist in understanding the clinical features of NBD due to regional variations and the lack of studies utilizing well-established diagnostic criteria. We therefore analyzed the clinical features of patients with NBD based on the recent international consensus recommendation. METHODS: We retrospectively searched electronic databases for patients with Behçet's disease (BD) between 2000 and 2017, and reviewed their medical records. Based on the recent international consensus recommendation, patients with definite or probable NBD were included. RESULTS: Of 9,817 patients with the diagnosis code for BD, 1,682 (17.1%) visited the neurology clinic and 110 (1.1%) were classified as NBD. Ninety-eight patients exhibited parenchymal NBD and 12 exhibited nonparenchymal NBD. Their age at the onset of NBD was 37.6±10.6 years and the male-to-female ratio was 1.24:1. Brainstem syndrome (43.9%) was the most common condition in the 98 patients with parenchymal NBD, followed by multifocal (32.7%) and spinal cord (12.2%) syndromes. 72.4% exhibited acute NBD and 27.6% exhibited a progressive disease course. Frequent manifestations included pyramidal signs (52.0%), headache (45.9%), dysarthria (42.9%), and fever (31.6%). A frequent pattern in brain MRI was an upper brainstem lesion extending to the thalamus and basal ganglia. CONCLUSIONS: Approximately 1% of the patients with suspected BD exhibited NBD. Neurologists must understand the clinical characteristics of NBD in order to perform the differential diagnosis and management of these patients.
Basal Ganglia
;
Brain
;
Brain Stem
;
Classification
;
Consensus
;
Diagnosis
;
Diagnosis, Differential
;
Dysarthria
;
Fever
;
Headache
;
Humans
;
Korea
;
Magnetic Resonance Imaging
;
Medical Records
;
Neurology
;
Retrospective Studies
;
Spinal Cord
;
Thalamus
3.Centennial History of Yonsei University Dermatology in Korea: 1917 to 2017.
Jihee KIM ; Tae Gyun KIM ; Si Hyung LEE ; Min Kyung LEE ; Jong Hoon KIM ; Sang Eun LEE ; Do Young KIM ; Mi Ryung ROH ; Chang Ook PARK ; Ju Hee LEE ; Min Geol LEE ; Dongsik BANG ; Sang Ho OH ; Kee Yang CHUNG
Annals of Dermatology 2018;30(5):513-521
Yonsei Dermatology celebrated its centennial in 2017, marking 100 years since Kung Sun Oh established the first Department of Dermatology and Urology in Korea in 1917. Following the footsteps of Kung Sun Oh, a pioneer of Korean dermatology, its members united and worked to provide the best medical service and achieve academic milestones in dermatology. Over the past hundred years, Yonsei Dermatology has played a pivotal role in the advancement of medical science and academia in Korea. The main activities of the department include medical care, education, and dermatologic research. Its research activities have encompassed a wide spectrum of dermatologic manifestations from skin immunology and pathology to introduction of newly developed treatment technologies. As Kung Sun Oh was the first Korean professor of dermatology at Severance Medical School and a passionate educator, we continue to serve his will by nurturing medical students and dermatology specialists to serve as global medical leaders. The Kung Sun Oh Memorial Lecture, first hosted in 1977, was the beginning of mutual international academic exchange in the field of dermatology in Korea. The memorial lecture has played a major role in advancing the academic status of Korean dermatological science by inviting distinguished dermatologists from around the world as guest lecturers. Yonsei Dermatology has played a key role in the history of modern medicine and dermatology in Korea over the last 100 years and continues to make an impact.
Allergy and Immunology
;
Dermatology*
;
Education
;
History, Modern 1601-
;
Humans
;
Korea*
;
Pathology
;
Schools, Medical
;
Skin
;
Solar System
;
Specialization
;
Students, Medical
;
Urology
4.Thiopurine S-Methyltransferase Polymorphisms in Korean Dermatologic Patients.
Minseok LEE ; Jimyung SEO ; Dongsik BANG ; Do Young KIM
Annals of Dermatology 2017;29(5):529-535
BACKGROUND: Thiopurine S-methyltransferase (TPMT) is an important enzyme in the metabolism of thiopurines including azathioprine (AZA), 6-mercaptopurine, and 6-thioguanine. TPMT genotyping is widely used for screening of AZA-related toxicity during routine clinical practice in Korea. However, the data of TPMT genotypes and its AZA-related toxicity have not been studied in the field of dermatology. OBJECTIVE: The aim of this study was to evaluate the genetic basis of TPMT polymorphism in Korean dermatologic patients and subsequently to investigate the relationship between mutant TPMT and adverse responses to AZA treatment. METHODS: This study was retrospective, single-center study. One hundred forty-nine Korean dermatologic patients who underwent TPMT screening test were included. Each patient's medical records, the result of TPMT screening test, dose and treatment period of AZA, and side effects, were reviewed. Laboratory tests were assessed at each visit in order to monitor adverse drug reactions. Leukopenia grading was used in accordance with the common terminology criteria for adverse events (CTCAE) ver. 4.03. RESULTS: Behçet's disease was the leading disorder among the patients. The frequency of TPMT mutation was 4.0% (6/149) among the participants in this study. Four of the six patients with genetic alterations were treated with a low-dose AZA regimen, but no AZA-related adverse events were observed. CONCLUSION: Our results suggest that 1) TPMT polymorphisms in Korean dermatologic patients are similar to those previously reported in Asian patients with the most common mutant allele being TPMT*3C and 2) AZA can be used in the patients with these polymorphisms under a careful dosing regimen.
6-Mercaptopurine
;
Alleles
;
Asian Continental Ancestry Group
;
Azathioprine
;
Behcet Syndrome
;
Dermatology
;
Drug-Related Side Effects and Adverse Reactions
;
Genotype
;
Humans
;
Korea
;
Leukopenia
;
Mass Screening
;
Medical Records
;
Metabolism
;
Retrospective Studies
;
Thioguanine
5.Early Roots of Western Medicine and a Pioneer of Social Work in Korea: Dr. Kung Sun Oh (1878-1963).
Yonsei Medical Journal 2016;57(2):277-282
No abstract available.
6.Carpal Tunnel Syndrome in Behcet's Disease.
Jungsoo LEE ; Suhyun CHO ; Do Young KIM ; Zhenlong ZHENG ; Hoon PARK ; Dongsik BANG
Yonsei Medical Journal 2015;56(4):1015-1020
PURPOSE: Behcet's disease (BD) is a chronic inflammatory disease characterized by orogenital ulcers, skin and ocular lesions, in addition to articular, vascular, and neurologic symptoms. Carpal tunnel syndrome (CTS), can also occur in BD patients secondary to inflammation in the connective tissues, vessels, and tendons, as well as nerve involvement in BD itself. However, reports of patients who have CTS in BD are rare. The aim of this study was to evaluate the clinical characteristics of CTS in BD patients. MATERIALS AND METHODS: Retrospective analysis of the medical records of 1750 BD patients, and 14 (0.8%) BD patients who were diagnosed with CTS was performed at the BD Specialty Clinic of Severance Hospital. Patient demographics, disease activity/severity for both diseases, and the clinical characteristics of CTS in BD were recorded and analyzed. RESULTS: All 14 BD patients with CTS were women. Twelve patients (85.7%) were diagnosed with active BD. The CTS was mild in 8 patients (57.2%), moderate in 3 patients (21.4%), and severe in 3 patients (21.4%). Ten patients (71.4%) had BD prior to the diagnosis of CTS, and these 10 patients all had active BD. CONCLUSION: CTS can occur as a result of the inflammation associated with BD and can also be the presenting symptom of nerve involvement in BD. CTS can also develop as the initial symptom of BD. Therefore, a higher degree of suspicion should be maintained for CTS in patients with BD and vice versa; however, the exact relationship is uncertain.
Adult
;
Age Distribution
;
Aged
;
Behcet Syndrome/complications/diagnosis/*epidemiology
;
Carpal Tunnel Syndrome/diagnosis/*epidemiology
;
Female
;
Humans
;
Inflammation
;
Male
;
Middle Aged
;
Retrospective Studies
;
Sex Distribution
7.Renal Manifestations in 2007 Korean Patients with Behcet's Disease.
Sung Bin CHO ; Jihyun KIM ; Shin Wook KANG ; Tae Hyun YOO ; Zhenlong ZHENG ; Suhyun CHO ; Hye Sun LEE ; Dongsik BANG
Yonsei Medical Journal 2013;54(1):189-196
PURPOSE: Behcet's disease (BD) theoretically affects all sizes and types of blood vessels and results in multi-organ involvement. However, renal BD has not been fully characterized, though the kidneys are histologically rich in blood vessels. MATERIALS AND METHODS: A total of 2007 patients who fulfilled the diagnostic criteria for BD were enrolled in this study. We reviewed the medical records and test results of the BD patients and used univariate and multivariate logistic regression analyses to determine the clinical significance of renal involvement in BD. RESULTS: Among the 2007 BD patients, we noted hematuria in 412 (20.5%) and proteinuria in 29 (1.4%). Univariate analysis showed that the BD patients with hematuria were predominantly female and older, had higher erythrocyte sedimentation rates (ESRs), and more frequently presented with genital ulcerations. BD patients with proteinuria had higher ESR levels compared to BD patients without proteinuria. In the multivariate analysis, age, sex, and ESR were found to be significantly associated with hematuria in BD patients, whereas only ESR was associated with proteinuria in BD patients. We also found that IgA nephropathy was the most common pathologic diagnosis in 12 renal BD patients who underwent renal biopsies. CONCLUSION: We suggest that routine urinalysis and serum renal function tests be performed for the early detection of renal BD, especially in older female BD patients with recurrent hematuria, high ESR levels, and frequent genital ulcers, as well as in BD patients with proteinuria and high ESR levels.
Adolescent
;
Adult
;
Age Factors
;
Aged
;
Aged, 80 and over
;
Behcet Syndrome/*complications/epidemiology/*metabolism
;
Biopsy
;
Female
;
Glomerulonephritis, IGA/complications/diagnosis
;
Hematuria/complications/diagnosis
;
Humans
;
Kidney/*pathology
;
Kidney Diseases/*diagnosis
;
Logistic Models
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Proteinuria/complications/diagnosis
;
Republic of Korea
;
Young Adult
8.Anti-Cyclic Citrullinated Peptide Antibodies and Joint Involvement in Behcet's Disease.
Sung Bin CHO ; Ju Hee LEE ; Keun Jae AHN ; Byung Gi BAE ; Taegyun KIM ; Yong Beom PARK ; Soo Kon LEE ; Kwang Hoon LEE ; Dongsik BANG
Yonsei Medical Journal 2012;53(4):759-764
PURPOSE: We aimed to determine the prevalence of anti-cyclic citrullinated peptide (anti-CCP) antibodies in a large group of Korean patients with Behcet's disease (BD), with and without joint involvement, and to compare these findings with the prevalences of anti-CCP antibodies in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). MATERIALS AND METHODS: We tested 189 patients with BD, 105 with RA, and 36 with SLE for anti-CCP antibodies and IgM rheumatoid factor in serum. We reviewed the medical records of patients with BD to investigate their personal and clinical characteristics as well as their laboratory test results. RESULTS: Anti-CCP antibodies were detected in seven of the 189 BD patients (3.7%), at a mean titer of 30.6+/-44.4 U/mL, in 86 of the 105 RA patients (81.9%) with a mean titer of 198.8+/-205.7 U/mL, and in nine of the 36 SLE patients (25%) with a mean titer of 180.4+/-113.9 U/mL. One of the seven anti-CCP-positive BD patients fulfilled the diagnostic criteria for both BD and RA. Five of the seven anti-CCP-positive BD patients (71.4%) had polyarticular joint involvement, and the other two patients (28.6%) had oligoarticular involvement. CONCLUSION: We determined the prevalence of anti-CCP antibodies in a large group of Korean BD patients with and without joint involvement. Negative anti-CCP test in patients with BD may help to differentiate BD from RA and SLE, all of which present with similar clinical features.
Adolescent
;
Adult
;
Aged
;
Antibodies/*blood
;
Arthritis, Rheumatoid/blood/immunology
;
Behcet Syndrome/*blood/immunology
;
Child
;
Female
;
Humans
;
Lupus Erythematosus, Systemic/blood/immunology
;
Male
;
Middle Aged
;
Peptides, Cyclic/*immunology
;
Young Adult
9.New Insights in the Clinical Understanding of Behcet's Disease.
Sung Bin CHO ; Suhyun CHO ; Dongsik BANG
Yonsei Medical Journal 2012;53(1):35-42
Behcet's disease is a chronic relapsing multisystemic inflammatory disorder characterized by four major symptoms (oral aphthous ulcers, genital ulcers, skin lesions, and ocular lesions) and occasionally by five minor symptoms (arthritis, gastrointestinal ulcers, epididymitis, vascular lesions, and central nervous system symptoms). Although the etiology of Behcet's disease is still unknown, there have been recent advances in immunopathogenic studies, genome-wide association studies, animal models, diagnostic markers, and new biological agents. These advances have improved the clinical understanding of Behcet's disease and have enabled us to develop new treatment strategies for this intractable disease, which remains one of the leading causes of blindness.
Animals
;
*Behcet Syndrome/epidemiology/immunology/therapy
;
Biological Therapy/*trends
;
Disease Models, Animal
;
Humans
;
Prevalence
;
*World Health
10.Retraction: Basal Cell Nevus Syndrome Showing Several Histologic Types of Basal Cell Carcinoma.
Annals of Dermatology 2012;24(2):242-242
No abstract available.

Result Analysis
Print
Save
E-mail